Loading…
Loading…
Home › All recalls › Prescription medicine
Category
Prescription drugs recalled for contamination, potency or labelling.
Or try another category
2,102 recalls · newest first
Subpotent product:out of specification assay results observed during long term stability testing.
Subpotent product:out of specification assay results observed during long term stability testing.
Correct Labeled Product Mispack-Size stated on carton label did not match the size of the bottle in the carton.
Presence of Foreign Tablets/Capsules
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
Why this is here: It was found to contain a drug or chemical that is not on the label. That is different from an allergen or a contamination scare: anyone taking it has been taking a substance nobody prescribed, in an unknown dose, and it can interact with medication they are already on. Follow the agency notice rather than judging it by how the product looks.
CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit
Why this is here: It was found to contain a drug or chemical that is not on the label. That is different from an allergen or a contamination scare: anyone taking it has been taking a substance nobody prescribed, in an unknown dose, and it can interact with medication they are already on. Follow the agency notice rather than judging it by how the product looks.
Cross Contamination with Other Products: Testing of reserve samples showed presence of traces of ezetimibe
Why this is here: It was found to contain a drug or chemical that is not on the label. That is different from an allergen or a contamination scare: anyone taking it has been taking a substance nobody prescribed, in an unknown dose, and it can interact with medication they are already on. Follow the agency notice rather than judging it by how the product looks.
Incorrect Product Formulation
Cross Contamination with Other Products
Defective container: Preferred Pharmaceuticals received a letter from the manufacturer Glenmark, that the blister packs are not fully sealed and…
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.
Failed impurities/degradation specifications: out of specification results for Ganirelix acetate acrylic acid adduct impurity.
Sub potent drug: during the 9-month stability test conducted, the assay value for the affected lot was below specification limit.
Defective Container - A defect in the side-seal which allows leakage of product.
Microbial Contamination of Sterile Products; out of limit results obtained for endotoxin testing.
Defective container - seal not adhering to bottles
Defective container: cracked/broken cartridges
Defective container: cracked/broken cartridges